The cost associated with diabetes, $245 billion at last count, has led several companies to develop digital health tools to help either medical professionals or patients do a better job of managing their health. Boosting adherence through different approaches to patient engagement or health literacy is a constant theme. The idea is to reduce healthcare costs associated with the condition.
EOS Health, one of the companies in this space, has raised $8.2 million, according to a filing with the U.S. Securities and Exchange Commission. Its Living Well with Diabetes program includes a platform which transmits real-time information, feedback and support to users to provide a more personalized health management tool. Although it is designed to help people manage their chronic conditions, diabetes is primary target. It was founded by Kim Angelides in 2009.
The company declined to comment on the fundraise.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Last fall, it announced that it had secured new investment from a new investor, 7wire Ventures. The Chicago-based investment group supports portfolio companies that focus on consumer-facing mobile health tools that personalize how users manage their healthcare, and decision-making tools in healthcare.
It also beefed up its executive team. It added Joe Carey and Stephanie Kowalski from Allscripts as a COO and chief marketing officer. It also hired Phil Donenberg, who had worked for BioSante and Unimed, as chief financial officer.
